Get the Stockscreener App
25.77
2.79%
-0.745
Assembly Biosciences Inc stock is traded at $25.77, with a volume of 15,507.
It is down -2.79% in the last 24 hours and up +17.94% over the past month.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
See More
Previous Close:
$26.51
Open:
$26.51
24h Volume:
15,507
Relative Volume:
0.13
Market Cap:
$198.44M
Revenue:
-
Net Income/Loss:
$-61.23M
P/E Ratio:
-1.9058
EPS:
-13.5194
Net Cash Flow:
$22.49M
1W Performance:
+5.27%
1M Performance:
+17.94%
6M Performance:
+183.81%
1Y Performance:
+47.59%
1-Day Range:
$25.75
$26.51
1-Week Range:
$23.21
$27.17
52-Week Range:
$7.75
$27.17
Assembly Biosciences Inc Stock (ASMB) Company Profile
Name
Assembly Biosciences Inc
Sector
Industry
Phone
(833) 409-4583
Address
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Compare ASMB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
25.86 | 203.39M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
405.64 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.22 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
542.01 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
795.45 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
326.40 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-25 | Initiated | Citizens JMP | Mkt Outperform |
| Aug-18-25 | Resumed | H.C. Wainwright | Buy |
| Mar-25-25 | Initiated | Guggenheim | Buy |
| Sep-20-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-13-21 | Initiated | H.C. Wainwright | Neutral |
| Sep-02-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Mar-23-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Nov-06-20 | Downgrade | Jefferies | Buy → Hold |
| Oct-19-20 | Initiated | Truist | Buy |
| Oct-16-19 | Initiated | Mizuho | Buy |
| Nov-19-18 | Initiated | Leerink Partners | Outperform |
| Oct-08-18 | Upgrade | B. Riley FBR | Neutral → Buy |
| Aug-08-18 | Initiated | Robert W. Baird | Outperform |
| Apr-13-18 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jan-05-18 | Initiated | B. Riley FBR, Inc. | Neutral |
| Nov-08-17 | Initiated | Jefferies | Buy |
| May-30-17 | Initiated | Chardan Capital Markets | Buy |
View All
Assembly Biosciences Inc Stock (ASMB) Latest News
Real time social sentiment graph for Assembly Biosciences Inc.Weekly Investment Report & Fast Entry Momentum Alerts - newser.com
Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue Estimates - MSN
Assembly Biosciences (NASDAQ:ASMB) Shares Cross Above 200-Day Moving AverageTime to Sell? - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Shares Cross Above 200-Day Moving Average – Time to Sell? - Defense World
Assembly Bio reports positive interim data for genital herpes drug By Investing.com - Investing.com Nigeria
Assembly Biosciences Inc. stock chart pattern explainedQuarterly Profit Report & Risk Managed Investment Strategies - newser.com
Assembly Biosciences (ASMB) Reveals Promising Interim Data for H - GuruFocus
Assembly Biosciences Presents Interim Phase 1b Data for HSV Helicase-Primase Inhibitor Candidate ABI-5366 at the 38th Congress of the International Union Against Sexually Transmitted Infections (IUSTI)- Europe - The Manila Times
Does Assembly Biosciences Inc. show high probability of rebound - newser.com
Will Assembly Biosciences Inc. (V7B) stock outperform small cap peers2025 Price Action Summary & High Conviction Investment Ideas - newser.com
Assembly Biosciences' (ASMB) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
What drives Assembly Biosciences Inc stock priceLong-Term Investment Plans & High Yield Investment Portfolio - earlytimes.in
Using economic indicators to assess Assembly Biosciences Inc. potentialWeekly Trade Analysis & Reliable Entry Point Alerts - newser.com
Will Assembly Biosciences Inc. (V7B) stock hit analyst forecasts2025 Market Outlook & Fast Momentum Stock Entry Tips - newser.com
Will Assembly Biosciences Inc. (V7B) stock outperform benchmarksMarket Performance Report & AI Powered Buy and Sell Recommendations - newser.com
Why analysts upgrade Assembly Biosciences Inc. stock2025 Trading Volume Trends & AI Driven Stock Reports - newser.com
What MACD and RSI say about Assembly Biosciences Inc.Weekly Trade Review & Risk Managed Investment Entry Signals - newser.com
What momentum shifts mean for Assembly Biosciences Inc.Gold Moves & Expert Approved Trade Ideas - newser.com
What indicators show strength in Assembly Biosciences Inc.Weekly Earnings Recap & AI Based Buy/Sell Signal Reports - newser.com
Real time scanner hits for Assembly Biosciences Inc. explainedJuly 2025 Decliners & Fast Exit and Entry Strategy Plans - newser.com
How Assembly Biosciences Inc. (V7B) stock moves on employment dataJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com
What consensus target says about Assembly Biosciences Inc. (V7B) stockJuly 2025 Highlights & Community Supported Trade Ideas - newser.com
Is Assembly Biosciences Inc. stock entering bullish territoryEarnings Growth Summary & Verified Stock Trade Ideas - newser.com
Does Assembly Biosciences Inc. qualify in momentum factor screeningJuly 2025 Momentum & Fast Entry High Yield Stock Tips - newser.com
Will Assembly Biosciences Inc. (V7B) stock attract long term capital inflowsMarket Volume Summary & Short-Term Trading Opportunity Alerts - newser.com
Visualizing Assembly Biosciences Inc. stock with heatmaps2025 Market WrapUp & Expert Approved Trade Ideas - newser.com
Assembly Biosciences (NASDAQ:ASMB) Share Price Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
Visual trend scoring systems applied to Assembly Biosciences Inc.Weekly Profit Summary & Safe Capital Investment Plans - newser.com
Assembly Biosciences (NASDAQ:ASMB) Share Price Passes Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Assembly Biosciences Inc Stock Analysis and ForecastInflation Impact on Stocks & Start Your Free Trading Journey Today - earlytimes.in
Published on: 2025-09-30 04:08:41 - newser.com
Assembly Biosciences Inc Stock (ASMB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Assembly Biosciences Inc Stock (ASMB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bjorkquist Jeanette M | Principal Accounting Officer |
Mar 31 '25 |
Sale |
9.85 |
180 |
1,773 |
4,617 |
| Okazaki Jason A | CEO and President |
Mar 31 '25 |
Sale |
9.85 |
355 |
3,496 |
14,757 |
| White Nicole S | Chief Manufacturing Officer |
Mar 31 '25 |
Sale |
9.85 |
197 |
1,940 |
11,674 |
| Houghton Michael | Director |
Dec 30 '24 |
Buy |
15.61 |
3,202 |
49,998 |
3,202 |
| GILEAD SCIENCES, INC. | 10% Owner |
Dec 19 '24 |
Buy |
21.37 |
940,499 |
20,098,464 |
2,209,471 |
| Schornstein Alexander | 10% Owner |
Nov 22 '24 |
Buy |
14.87 |
17,024 |
253,104 |
720,137 |
| Schornstein Alexander | 10% Owner |
Nov 25 '24 |
Buy |
14.91 |
7,976 |
118,890 |
728,113 |
| White Nicole S | Chief Manufacturing Officer |
Nov 18 '24 |
Sale |
16.29 |
40 |
652 |
11,871 |
2.36%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):